Intrinsic Value of S&P & Nasdaq Contact Us

Baxter International Inc. BAX NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
43/100
2/7 Pass
SharesGrow Intrinsic Value
$25.54
+45.2%
Analyst Price Target
$19.75
+12.3%

Baxter International Inc. (BAX) — Analyst outlook / Analyst consensus target is. Based on 36 analyst ratings, the consensus is bullish — 15 Buy, 20 Hold, 1 Sell.

The consensus price target is $19.75 (low: $15.00, high: $25.00), representing an upside of 12.3% from the current price $17.59.

Analysts estimate Earnings Per Share (EPS) of $1.84 and revenue of $10.56B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-1.27 vs est $1.84 (missed -169.1%). 2025: actual $-1.75 vs est $2.37 (missed -174%). Analyst accuracy: 0%.

BAX Stock — 12-Month Price Forecast

$19.75
▲ +12.28% Upside
Average Price Target
Based on 36 Wall Street analysts offering 12-month price targets for Baxter International Inc., the average price target is $19.75, with a high forecast of $25.00, and a low forecast of $15.00.
The average price target represents a +12.28% change from the last price of $17.59.
Highest Price Target
$25.00
Average Price Target
$19.75
Lowest Price Target
$15.00

BAX Analyst Ratings

Hold
36
Ratings
15 Buy
20 Hold
1 Sell
Based on 36 analysts giving stock ratings to Baxter International Inc. in the past 3 months
Rating breakdown
Buy
15 42%
Hold
20 56%
Sell
1 3%
42%
Buy
15 analysts
56%
Hold
20 analysts
3%
Sell
1 analysts

EPS Estimates — BAX

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual –$1.27 vs Est $1.84 ▼ 244.7% off
2025 Actual –$1.75 vs Est $2.37 ▼ 235.2% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect the company to turn profitable.

Revenue Estimates — BAX

99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $10.636B vs Est $10.557B ▲ 0.7% off
2025 Actual $11.244B vs Est $11.083B ▲ 1.4% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message